Skip to main content
. 2011 May 15;10:17. doi: 10.1186/1744-859X-10-17

Table 2.

Demographic and clinical characteristics of the sensitivity-psychoticism dominant groups according to treatment

Buprenorphine (N = 15) Methadone, (N = 16) P value
N (%) N (%) χ2

Gender (males) 13 (86.7) 14 (87.5) 0.00 0.944

Work: 7.72 0.052

 Student 0 (0.0) 1 (6.3)

 Blue collar 2 (20.0) 3 (18.8)

 White collar 11 (73.3) 5 (31.3)

 Unemployed 1 (6.7) 7 (43.8)

Education: >8 years 4 (26.7) 5 (31.3) 0.07 0.778

Civil status: single 13 (86.7) 12 (75.0) 0.67 0.411

Somatic comorbidity 10 (66.7) 13 (81.3) 0.85 0.350

Psychiatric comorbidity 10 (66.7) 14 (93.3) 3.33 0.060

Work major problems 0 (0.0) 7 (46.7) 9.1 0.002

Household major problems 14 (93.3) 13 (81.3) 1.00 0.315

Sexual major problems 12 (80.0) 13 (81.3) 0.00 0.929

Social-leisure major problems 11 (73.3) 12 (75.0) 0.01 0.915

Legal problems 2 (13.3) 6 (37.3) 2.36 0.124

Polyabuse 9 (60.0) 10 (62.5) 0.02 0.886

Past unsuccessful treatments 8 (53.3) 16 (100.0) 9.64 0.001

Mean ± SD Mean ± SD T*

Age 27 ± 5 30 ± 4 -1.90 0.067

Age at first use, years 18 ± 5 19 ± 5 -0.75 0.463

Age at dependence onset, years 20 ± 5 23 ± 5 -1.09 0.284

Dependence duration, months 53 ± 40 75 ± 46 -1.36 0.186

Age at first treatment, years 22 ± 5 25 ± 4 -1.54 0.136

Heroin PCC 89.16 ± 27.5 83.96 ± 17.9 0.62 0.542

Heroin TEC 21.84 ± 13.9 25.59 ± 15.4 -0.70 0.490

Cocaine PCC 94.16 ± 13.3 85.83 ± 16.3 1.56 0.130

Cocaine TEC 22.88 ± 12.6 23.60 ± 16.5 -0.12 0.902

* Student T-test; PCC = Percent 'clean'; TEC = Total Executed 'Clean'